Search

(GlobeNewswire) - Biogen Inc. (Nasdaq: BIIB) today announced positive topline results from its Phase 2 CONVEY study of vixotrigine(BIIB074), anon-opioidinvestigational oral pain drug being evaluated for the treatment of small [...]

Biogens non-opioid pain therapy did not reduce average daily pain as intended during a midstage study, but patients did report an overall improvement in the pain they experience. The phase [...]

(GlobeNewswire) - Saint-Herblain (France), September 14, 2021 Valneva SE, a specialty vaccine company, today announced that it has completed recruitment of the initial cohort of elderly participants in Valnevas Phase [...]

Pharming Group N.V. ('Pharming' or 'the Company') (Euronext Amsterdam: PHARM/NASDAQ: PHAR) announces the topline results from two randomized, open label, controlled, pilot clinical trials of patients hospitalized with COVID-19 treated [...]

Two Covid-19 vaccine candidates developed by Chinese and French and British multinational companies have received permission from the government for conducting clinical trials in Nepal. Officials said a messenger RNA [...]

Taiwanese vaccine producer Adimmune Corp. said on Monday that it has gained approval from the Indonesian government to conduct Phase 2 clinical trials for its COVID-19 vaccine candidate, with results [...]

(GlobeNewswire) - AzurRx BioPharma, Inc. (AzurRx or the Company) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, therapies forgastrointestinal (GI) diseases, today announced the activation of seven [...]

Vaccine company Novavax has begun early clinical trials to test a combined Covid and flu jab. A study based in Australia will include 640 healthy adults aged 50 to 70 [...]

(GlobeNewswire) - Connect Biopharma Holdings Limited (Nasdaq: CNTB) ('Connect Biopharma' or the Company), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through [...]

Chinese vaccine producer China National Biotec Group (CNBG), a Sinopharm subsidiary, announced that it has obtained approval of clinical trials for a COVID-19 drug based on human immuneglobulin developed from [...]

British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a Covid-19 jab after positive early results, they announced Tuesday. The vaccine is facing [...]

British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a Covid-19 jab after positive early results, they announced Tuesday. The vaccine is facing [...]

After the government allowed a Covid-19 vaccine developed by Chinese companies to conduct a third phase trial last week, two other foreign companies have also applied with the Nepal Health [...]

BlueWillow Biologics, Inc., a privately held clinical-stage biopharmaceutical company developing intranasal vaccines, today announced positive interim results from the Phase 1 clinical trial of BW-1010, its next-generation intranasal anthrax vaccine [...]

Clinical trials for a new COVID-19 vaccine are underway in East Tennessee and the Knoxville doctor in charge is seeking volunteers. Dr. Bill Smith with Alliance for Multispecialty Research, LLC [...]

Theravance Biopharma, Inc. ('Theravance Biopharma' or the 'Company') (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development, and commercialization of organ-selective medicines, today announced top-line results from [...]

India has authorized emergency use of another Indian-made COVID-19 vaccine, after its producer said it prevented symptomatic infections in two-thirds of recipients. Regulators approved ZyCoV-D even though theres no publicly [...]

(GlobeNewswire) - AzurRx BioPharma, Inc. (AzurRx or the Company) (NASDAQ: AZRX), a company specializing in the development of targeted, non-systemictherapies forgastrointestinal (GI) diseases, today announced positive topline results from its [...]

Trials for a new Covid-19 vaccine are under way around the country as New Zealand is one of the few places with enough people how haven't been exposed to the [...]

The first phase of human clinical trials for a Covid-19 vaccine produced by Spanish firm Hipra was approved by the pharmaceuticals agency of Spain on Tuesday. The clinical trials will [...]

Chulalongkorn Universitys Faculty of Pharmaceutical Sciences will start the first phase of clinical trials on Thailands plant-based coronavirus vaccine, called the Baiya Vaccine, next month with 100 volunteers taking part. [...]

The kingdom's plant-based coronavirus vaccine is set to start its first phase of clinical trials next month with 100 volunteers taking part. Known as the 'Baiya Vaccine', the subunit vaccine, [...]

The Russian Direct Investment Fund (RDIF) proposes to Pfizer a joint clinical trial to analyze the efficacy of both vaccines to tackle the impact of the latest COVID-19 variants. 'The [...]

(GlobeNewswire) - AzurRx BioPharma, Inc. (AzurRx or the Company) (NASDAQ: AZRX), a company specializing in the development of targeted, non-systemic therapies forgastrointestinal (GI) diseases, today announced that it has completed [...]

(GlobeNewswire) - Ultimovacs ASA ('Ultimovacs') (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announced positive topline results from the second cohort of 10 patients after one [...]

(GlobeNewswire) - Saint-Herblain (France), August 11th, 2021 Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases [...]

Spains medicines agency approved Tuesday a first round of clinical trials on humans for a Covid-19 vaccine developed by Spanish firm Hipra. This is the first trial on humans of [...]

China has approved two clinical trials on the sequential immunization strategy of the China-US jointly developed DNA COVID-19 vaccine and Sinovac's inactivated vaccines to enhance the immunogenicity of vaccines facing [...]

BioInvent International AB ('BioInvent') (Nasdaq Stockholm: BINV) today announced that it has entered into a second clinical trial collaboration and supply agreement with MSD, a tradename of Merck & Co., [...]

(GlobeNewswire) - Pivotal study VLA1553-301 met its primary endpoint Vaccine candidate induced protective CHIKV neutralizing antibody titers in 98.5% of subjects after a single vaccination VLA1553 was well tolerated across [...]

Vaxart, Inc., (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines administered by tablet, announced today that the U.S. Food and Drug Administration has cleared Vaxart's Investigational New Drug application [...]

COVID-19 vaccine makers Pfizer-BioNTech and Moderna are expanding their clinical trials for children aged 5 to 11 at the urging of the Food and Drug Administration (FDA), according to a [...]

Biogen and partner Eisai are pressing ahead to gather more data about their Alzheimers disease drug, Aduhelm, and they have now revealed plans for a 6,000 patient real-world study. To [...]

A clinical trial proposal on mixing two different vaccine doses is yet to get the Drugs Controller General of Indias approval, a Health Ministry source said. The proposal seeks to [...]

The development of the COVID-19 vaccine for children is in the advanced stages of clinical trials and as soon as researchers get robust results, the administration will decide on vaccinating [...]

Brazils health surveillance agency Anvisa on Friday suspended permission for a planned clinical trial of Indias homegrown Covid-19 vaccine Covaxin made by Bharat Biotech, hours after the vaccine maker cut [...]

(GlobeNewswire) - Saint-Herblain (France) and New York, NY, July 19, 2021 Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the development and commercialization of prophylactic [...]

(GlobeNewswire) - ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today provided an update on ASPEN-COVID-19, the [...]

Artax Biopharma, Inc., a biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today announced that the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) has granted [...]

The Department of Biotechnology (DBT) in Ministry of Science & Technology has announced that it has approved additional funding towards clinical studies of Indias first of its kind mRNA-based Covid-19 [...]

(GlobeNewswire) - Biogen (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) today announced the U.S. Food and Drug Administration (FDA) has approved an updated label for ADUHELM (aducanumab-avwa) injection 100 [...]

Medigen Vaccine Biologics Corp (????) has applied to Paraguays National Health Monitoring Directorate to conduct phase 3 clinical trials for its COVID-19 experimental vaccine in the country, the company said [...]

Eucure Biopharma, a wholly owned subsidiary of Biocytogen dedicated to developing antibody drugs with independent intellectual property rights, announced that the U.S. Food and Drug Administration (FDA) has approved two [...]

Taiwan's domestic COVID-19 vaccine producer Medigen Vaccine Biologics Corp. on Tuesday announced that it has officially applied to conduct Phase 3 clinical trials in Paraguay, Taiwan's only diplomatic ally in [...]

Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates to address the world's most life-threatening diseases and public health threats, today announced the completion [...]

Covaxin, the Covid-19 vaccine developed by Hyderabad-based vaccine maker Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been found to be 77.8 percent effective in [...]

(GlobeNewswire) - Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that the first patient in the United States [...]

An expert panel constituted by the government has recommended against granting permission to the Serum Institute of India (SII) to conduct phase two and three clinical trials of Covavax COVID-19 [...]

Emergex Vaccines, a UK-based biotech company, has received approval to initiate a Phase I clinical trial for its Dengue Fever vaccine candidate. The company develops vaccines to address major infectious [...]

Even as the Phase-3 trials of Covovax, the Indian version of US-based Novavax Inc-developed vaccine began on June 18, Serum Institute of India (SII) authorities said they will also apply [...]